These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9586151)

  • 1. [Marfan syndrome: diagnosis of cardiovascular manifestations].
    von Kodolitsch Y; Raghunath M; Dieckmann C; Nienaber CA
    Z Kardiol; 1998 Mar; 87(3):161-72. PubMed ID: 9586151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.
    Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A
    Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
    Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
    Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights.
    Furthmayr H; Francke U
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, pathological and molecular genetic findings in a case of neonatal Marfan syndrome.
    Bresters D; Nikkels PG; Meijboom EJ; Hoorntje TM; Pals G; Beemer FA
    Acta Paediatr; 1999 Jan; 88(1):98-101. PubMed ID: 10090557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marfan syndrome. Part 1: pathophysiology and diagnosis.
    Cañadas V; Vilacosta I; Bruna I; Fuster V
    Nat Rev Cardiol; 2010 May; 7(5):256-65. PubMed ID: 20351703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fibrillin 1 mutation in a case of neonatal Marfan syndrome: the increasing importance of early recognition.
    Sutherell J; Zarate Y; Tinkle BT; Markham LW; Cripe LH; Hyland JC; Witte D; Hopkin RJ; Hinton RB
    Congenit Heart Dis; 2007; 2(5):342-6. PubMed ID: 18377451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic management of patients with Marfan syndrome: focus on cardiovascular involvement.
    Nienaber CA; Von Kodolitsch Y
    Cardiol Rev; 1999; 7(6):332-41. PubMed ID: 11208245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marfan syndrome and fibrillin disorders.
    Le Parc JM; Molcard S; Tubach F; Boileau C; Jondeau G; Muti C; Chevallier B; Pisella PJ
    Joint Bone Spine; 2000; 67(5):401-7. PubMed ID: 11143906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic fibrillinopathies: new insights in molecular diagnosis and clinical management.
    Loeys BL; Matthys DM; de Paepe AM
    Acta Clin Belg; 2003; 58(1):3-11. PubMed ID: 12723256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised Ghent Criteria is Comparable to Original Diagnostic Criteria for Marfan Syndrome with Increased Ability to Clinically Diagnose Related Disorders.
    Penpattharakul W; Pithukpakorn M
    J Med Assoc Thai; 2016 Jan; 99(1):34-9. PubMed ID: 27455822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Marfan syndrome caused by an exon 25 mutation of the fibrillin-1 gene.
    Elçioglu NH; Akalin F; Elçioglu M; Comeglio P; Child AH
    Genet Couns; 2004; 15(2):219-25. PubMed ID: 15287423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders.
    Aoyama T; Francke U; Gasner C; Furthmayr H
    Am J Med Genet; 1995 Aug; 58(2):169-76. PubMed ID: 8533811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marfan syndrome and mitral valve prolapse.
    Weyman AE; Scherrer-Crosbie M
    J Clin Invest; 2004 Dec; 114(11):1543-6. PubMed ID: 15578086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of Marfan syndrome and Ehlers-Danlos type IV.
    Milewicz DM
    Curr Opin Cardiol; 1998 May; 13(3):198-204. PubMed ID: 9649943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Marfan syndrome].
    Kaitila I; Jokinen E; Kokkonen J
    Duodecim; 2012; 128(5):503-13. PubMed ID: 22486066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.
    Faivre L; Masurel-Paulet A; Collod-Béroud G; Callewaert BL; Child AH; Stheneur C; Binquet C; Gautier E; Chevallier B; Huet F; Loeys BL; Arbustini E; Mayer K; Arslan-Kirchner M; Kiotsekoglou A; Comeglio P; Grasso M; Halliday DJ; Béroud C; Bonithon-Kopp C; Claustres M; Robinson PN; Adès L; De Backer J; Coucke P; Francke U; De Paepe A; Boileau C; Jondeau G
    Pediatrics; 2009 Jan; 123(1):391-8. PubMed ID: 19117906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indirect genotype analysis as a diagnostic procedure in Marfan syndrome].
    Laudahn BM; Gyürüs P; Orth U; Gal A; Nienaber CA
    Z Kardiol; 2000 Oct; 89(10):939-48. PubMed ID: 11098545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies.
    Hayward C; Brock DJ
    Hum Mutat; 1997; 10(6):415-23. PubMed ID: 9401003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.